Retrospective Analysis of a Real-Life Use of Tixagevimab-Cilgavimab plus SARS-CoV-2 Antivirals for Treatment of COVID-19
Tixagevimab-cilgavimab is effective for the treatment of early COVID-19 in outpatients with risk factors for progression to severe illness, as well as for primary prevention and post-exposure prophylaxis. We aimed to retrospectively evaluate the hospital stay (expressed in days), prognosis, and nega...
Saved in:
Main Authors: | Nicolina Capoluongo (Author), Annamaria Mascolo (Author), Francesca Futura Bernardi (Author), Marina Sarno (Author), Valentina Mattera (Author), Giusy di Flumeri (Author), Bruno Pustorino (Author), Micaela Spaterella (Author), Ugo Trama (Author), Annalisa Capuano (Author), Alessandro Perrella (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy
by: M. V. Zhuravleva, et al.
Published: (2023) -
Immunogenicity and safety of tixagevimab-cilgavimab for COVID-19 pre-exposure prophylaxis in immunocompromised 20 to <40 kg children and adolescents: A pilot, prospective, open-labeled study
by: Jassada Buaboonnam, et al.
Published: (2024) -
Decolonization of drug-resistant Enterobacteriaceae carriers: A scoping review of the literature
by: Annamaria Mascolo, et al.
Published: (2023) -
Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database
by: Cristina Scavone, et al.
Published: (2022) -
Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy
by: Cristina Scavone, et al.
Published: (2019)